416 related articles for article (PubMed ID: 33953404)
1. AI-based pathology predicts origins for cancers of unknown primary.
Lu MY; Chen TY; Williamson DFK; Zhao M; Shady M; Lipkova J; Mahmood F
Nature; 2021 Jun; 594(7861):106-110. PubMed ID: 33953404
[TBL] [Abstract][Full Text] [Related]
2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
3. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
Posner A; Prall OW; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW
J Pathol; 2023 Jan; 259(1):81-92. PubMed ID: 36287571
[TBL] [Abstract][Full Text] [Related]
4. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
Lorkowski SW; Dermawan JK; Rubin BP
Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning.
Tian F; Liu D; Wei N; Fu Q; Sun L; Liu W; Sui X; Tian K; Nemeth G; Feng J; Xu J; Xiao L; Han J; Fu J; Shi Y; Yang Y; Liu J; Hu C; Feng B; Sun Y; Wang Y; Yu G; Kong D; Wang M; Li W; Chen K; Li X
Nat Med; 2024 May; 30(5):1309-1319. PubMed ID: 38627559
[TBL] [Abstract][Full Text] [Related]
6. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.
Vikeså J; Møller AK; Kaczkowski B; Borup R; Winther O; Henao R; Krogh A; Perell K; Jensen F; Daugaard G; Nielsen FC
BMC Cancer; 2015 Mar; 15():151. PubMed ID: 25885340
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
[TBL] [Abstract][Full Text] [Related]
8. An integrated tool for determining the primary origin site of metastatic tumours.
Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
Oien KA; Dennis JL
Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.
Ström P; Kartasalo K; Olsson H; Solorzano L; Delahunt B; Berney DM; Bostwick DG; Evans AJ; Grignon DJ; Humphrey PA; Iczkowski KA; Kench JG; Kristiansen G; van der Kwast TH; Leite KRM; McKenney JK; Oxley J; Pan CC; Samaratunga H; Srigley JR; Takahashi H; Tsuzuki T; Varma M; Zhou M; Lindberg J; Lindskog C; Ruusuvuori P; Wählby C; Grönberg H; Rantalainen M; Egevad L; Eklund M
Lancet Oncol; 2020 Feb; 21(2):222-232. PubMed ID: 31926806
[TBL] [Abstract][Full Text] [Related]
11. Cancers of unknown primary origin: current perspectives and future therapeutic strategies.
Stella GM; Senetta R; Cassenti A; Ronco M; Cassoni P
J Transl Med; 2012 Jan; 10():12. PubMed ID: 22272606
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP).
Ades F; de Azambuja E; Daugaard G; Ameye L; Moulin C; Paesmans M; De Jong D; Decoster L; De Greve J; Ismael G; Møller AK; Piccart M; Awada A
J Chemother; 2013 Aug; 25(4):239-46. PubMed ID: 23906077
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and therapeutic management of cancer of an unknown primary.
Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
[TBL] [Abstract][Full Text] [Related]
14. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
15. Capsule endoscopy to detect primary tumour site in metastatic neuroendocrine tumours.
Frilling A; Smith G; Clift AK; Martin J
Dig Liver Dis; 2014 Nov; 46(11):1038-42. PubMed ID: 25086997
[TBL] [Abstract][Full Text] [Related]
16. Validation of a Transcriptome-Based Assay for Classifying Cancers of Unknown Primary Origin.
Michuda J; Breschi A; Kapilivsky J; Manghnani K; McCarter C; Hockenberry AJ; Mineo B; Igartua C; Dudley JT; Stumpe MC; Beaubier N; Shirazi M; Jones R; Morency E; Blackwell K; Guinney J; Beauchamp KA; Taxter T
Mol Diagn Ther; 2023 Jul; 27(4):499-511. PubMed ID: 37099070
[TBL] [Abstract][Full Text] [Related]
17. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
[TBL] [Abstract][Full Text] [Related]
18. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.
Pantanowitz L; Quiroga-Garza GM; Bien L; Heled R; Laifenfeld D; Linhart C; Sandbank J; Albrecht Shach A; Shalev V; Vecsler M; Michelow P; Hazelhurst S; Dhir R
Lancet Digit Health; 2020 Aug; 2(8):e407-e416. PubMed ID: 33328045
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract][Full Text] [Related]
20. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]